Sintx Technologies (SINT) Net Income towards Common Stockholders (2013 - 2026)
Sintx Technologies (SINT) posted Net Income towards Common Stockholders of -$2.8 million for Q1 2026, down 27.36% on a QoQ basis from -$2.2 million in Q4 2025, and down 22.87% year-over-year from -$3.7 million in Q1 2025.
Analysis
Sintx Technologies (SINT) Net Income towards Common Stockholders (2013 - 2026) Analysis & Trends
Sintx Technologies has reported Net Income towards Common Stockholders for 14 years, with the latest figure at -$2.8 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 22.87% year-over-year to -$2.8 million in Q1 2026; TTM through Mar 2026 was -$17.6 million, a 41.64% decrease from a year earlier, with the FY2025 full-year figure at -$17.1 million, down 54.96% from the prior year.
- Net Income towards Common Stockholders was -$2.8 million for Q1 2026 at Sintx Technologies, down from -$2.2 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$1.7 million in Q4 2024, with the low at -$10.3 million in Q3 2025.
- Average Net Income towards Common Stockholders over 5 years is -$3.7 million, with a median of -$2.7 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 294.0% in 2022, then surged 72.4% in 2023.
- Over 5 years, Net Income towards Common Stockholders stood at -$8.4 million in 2022, then soared by 72.4% to -$2.3 million in 2023, then rose by 26.97% to -$1.7 million in 2024, then tumbled by 30.68% to -$2.2 million in 2025, then slipped by 27.36% to -$2.8 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$2.8 million (Q1 2026), -$2.2 million (Q4 2025), and -$10.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Mn |
| Dec 31, 2025 | -2.22 Mn |
| Sep 30, 2025 | -10.26 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | -6.24 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -3.73 Mn |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | -3.19 Mn |
| Jun 30, 2023 | -2.48 Mn |
| Mar 31, 2023 | -4.44 Mn |
| Dec 31, 2022 | -8.41 Mn |
| Sep 30, 2022 | -2.72 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -2.13 Mn |
| Sep 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.20 Mn |